Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has issued an update.
Hisamitsu Pharmaceutical Co. has finalized the details of stock compensation-type share options, initially resolved by the Board of Directors on July 10, 2025. The allocation involves 141 stock acquisition rights priced at 318,600 yen each, calculated using the Black-Scholes model based on the Tokyo Stock Exchange’s closing price. These rights are designated for six directors of the company, excluding outside directors, and are intended to align their interests with the company’s performance.
More about Hisamitsu Pharmaceutical Co
YTD Price Performance: -1.50%
Average Trading Volume: 157,206
Technical Sentiment Signal: Sell
Current Market Cap: Yen290.5B
For detailed information about 4530 stock, go to TipRanks’ Stock Analysis page.